Comparing Common Safety Outcomes in Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients Treated with Various First-line Platinum-containing Chemotherapy Combination Regimens (H3E-MC-B026) First published 23/01/2017 Last updated 02/04/2024 EU PAS number:EUPAS10688 Study Finalised